CKPT

3.13

1.57% -0.05

Handel nachbörslich: 3.12 -0.010 -0.32%

Checkpoint Therapeutics Inc (CKPT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.18

Offen:

$3.2

24-Stunden-Volumen:

612.05K

Relative Volume:

0.48

Marktkapitalisierung:

$152.85M

Einnahmen:

$103.00K

Nettoeinkommen (Verlust:

$-42.47M

KGV:

-1.6474

EPS:

-1.9

Netto-Cashflow:

$-34.30M

1W Leistung:

-5.44%

1M Leistung:

+4.33%

6M Leistung:

+38.50%

1J Leistung:

+63.02%

1-Tages-Spanne:

$3.11

$3.24

1-Wochen-Bereich:

$3.10

$3.425

52-Wochen-Spanne:

$1.38

$4.50

Checkpoint Therapeutics Inc Stock (CKPT) Company Profile

Firmenname

Checkpoint Therapeutics Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

781-652-4500

Adresse

95 SAWYER ROAD, WALTHAM, NY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

CKPT's Discussions on Twitter

Vergleichen Sie CKPT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CKPT Checkpoint Therapeutics Inc	3.13	152.85M	103.00K	-42.47M	-34.30M	-1.90
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-13	Eingeleitet	D. Boral Capital	Buy
2022-07-14	Fortgesetzt	B. Riley Securities	Buy
2021-06-09	Eingeleitet	B. Riley Securities	Buy
2021-01-20	Eingeleitet	Cantor Fitzgerald	Overweight
2019-05-29	Eingeleitet	Lake Street	Buy
2017-12-08	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Checkpoint Therapeutics Inc Aktie (CKPT) Neueste Nachrichten

Feb 17, 2025

Checkpoint Therapeutics CEO sells $64,027 in stock - MSN

Feb 17, 2025

Feb 16, 2025

James F. Oliviero III Sells 9,233 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Stock - MarketBeat

Feb 16, 2025

Checkpoint Therapeutics CFO sells shares worth $271,983 - MSN

Feb 16, 2025

Feb 14, 2025

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CEO James F. Oliviero III Sells 10,331 Shares - MarketBeat

Feb 14, 2025

Feb 12, 2025

Checkpoint Therapeutics CEO sells $64,027 in stock By Investing.com - Investing.com South Africa

Feb 12, 2025

Feb 11, 2025

The Future of Immune Checkpoint Inhibitors Market: Industry Disruptions & Innovations to Expect - WICZ

Feb 11, 2025

Checkpoint Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView

Feb 11, 2025

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO Sells $271,983.70 in Stock - MarketBeat

Feb 11, 2025

Insider Sale Alert: Checkpoint Therapeutics Inc [CKPT] – Is it Time to sell? - Knox Daily

Feb 11, 2025

Feb 08, 2025

Checkpoint Therapeutics CFO sells shares worth $271,983 By Investing.com - Investing.com Canada

Feb 08, 2025

Feb 06, 2025

The time has not yet come to remove your chips from the table: Checkpoint Therapeutics Inc (CKPT) - SETE News

Feb 06, 2025

Analyzing Ratios: Checkpoint Therapeutics Inc (CKPT)’s Financial Story Unveiled - The Dwinnex

Feb 06, 2025

Feb 05, 2025

Technical analysis of Checkpoint Therapeutics Inc (CKPT) stock chart patterns - US Post News

Feb 05, 2025

Feb 04, 2025

Checking in on Checkpoint Therapeutics Inc (CKPT) after recent insiders movement - Knox Daily

Feb 04, 2025